Delivery Order SPE2DB24D1205-SPE2DB25FCWFF
Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packaging) valued at $1,481.13, with a firm fixed price structure. This award, issued on November 25, 2025, represents a non-competitive delivery order with an ultimate completion date of November 26, 2025. The contract is performed out of AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $11,535.63 to AmerisourceBergen Drug Corp for 60 tablets of MULTAQ 400 mg on August 25, 2025, with a completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. MULTAQ (dronedarone) is an antiarrhythmic medication used in the treatment of atrial fibrillation and represents one...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,181.52 for 60 tablets of MULTAQ 400 mg on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $3,736.64 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MULTAQ (dronedarone) is an antiarrhythmic medication used to treat atrial fibrillation, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count units) on June 16, 2025, with an ultimate completion date of June 17, 2025. This contract, valued at $9,756.31, utilizes firm fixed price terms and was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) under a firm fixed-price contract valued at $29,062.23. The delivery order, issued on September 12, 2025, carries an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive award. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of MULTAQ 400 MG tablets (60-count units) under a firm fixed-price contract structure. This $15,506.29 delivery order represents a non-set-aside competitive award with a completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. MULTAQ is a cardiac antiarrhythmic medication, reflecting the Defense...
- The Defense Logistics Agency awarded a $1,232.98 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of Multaq (dronedarone) 400 mg tablets in a quantity of 60 units. The contract, which is not set-aside, has an ultimate completion date of May 19, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger indefinite delivery vehicle that...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on August 4, 2025, with a ceiling value of $40,373.44. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Multaq 400 mg tablets (60-count) valued at $9,625.47 under a firm fixed-price contract. This non-set-aside award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, headquartered in...